Follow up analysis by exosomal miRNAs in EGFR mutated non-small cell lung cancer (NSCLC) patients during osimertinib (AZD9291) treatment: A potential prognostic biomarker tool.

被引：14

作者：

Giallombardo, Marco

Chacartegui, Jorge Jorge

Reclusa, Pablo

Van Meerbeeck, Jan P.

Alessandro, Riccardo

Peeters, Marc

Pauwels, Patrick

Rolfo, Christian Diego

机构：

[1] Univ Antwerp Hosp, Dept Oncol, Phase Early Clin Trials Unit 1, Edegem, Belgium

[2] Univ Antwerp Hosp, Dept Thorac Oncol, Edegem, Belgium

[3] Univ Palermo, Dept Biopathol & Med & Forens Biotechnol, Palermo, Italy

[4] Univ Antwerp Hosp, Edegem, Belgium

[5] Univ Antwerp Hosp, Retie, Belgium

来源：

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.e23035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e23035

引用

页数：2